Patients and society set to benefit from innovation
It is exciting to see the advances in science, and the diversity in innovation coming from pharmaceutical companies to address these health challenges
It is exciting to see the advances in science, and the diversity in innovation coming from pharmaceutical companies to address these health challenges
New research published today by EFPIA provides in-depth analysis of the economic footprint
We are standing at a critical point where the challenges of European healthcare threaten the socio-economic stability of our societies
We represent innovative pharmaceutical industry in Slovenia and work as a non-governmental, non-profit, non-political and independent economic interest group. We connect 22 pharmaceutical companies which share a common goal: #WeWontRest in developing innovative medicines which hold the key to managing diseases and to improving the lives of patients.